Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00051883 · ClinicalTrials.gov registry record

Chemical Dependency and Smoking Cessation: Patient's Views - 1

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
125
Enrollment target

NCT00051883: Completed study, sponsored by National Institute on Drug Abuse (NIDA).

NCT00051883 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00051883 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
125 participants
Enrollment target

Study Summary

The purpose of this study is to asses patient views on smoking cessation and tobacco harm reduction during drug treatment.

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 1999-12
Est. Completion 2005-02

What the finished NCT00051883 record still lists

NCT00051883 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00051883 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00051883 about?

NCT00051883 is a clinical study titled "Chemical Dependency and Smoking Cessation: Patient's Views - 1". The purpose of this study is to asses patient views on smoking cessation and tobacco harm reduction during drug treatment.

What is the current status of trial NCT00051883?

This trial is currently completed. The enrollment target is 125 participants. The study started on 1999-12. Estimated completion is 2005-02.

Who is sponsoring clinical trial NCT00051883?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00051883, the US trial registry maintained by the National Library of Medicine. NCT00051883 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.